Key Insights

Highlights

Success Rate

33% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

50.0%

2 terminated out of 4 trials

Success Rate

33.3%

-53.2% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results33% success

Data Visualizations

Phase Distribution

2Total

Not Applicable (1)

P 2 (1)

Trial Status

Terminated2

Recruiting1

Completed1

Trial Success Rate

33.3%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials

NCT01005654Recruiting

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

NCT03986593Not ApplicableTerminated

Cryoablation of Bone Metastases From Endocrine Tumors

NCT05888753Completed

Textbook Outcome in Adrenal Neoplasms

NCT02001051Phase 2Terminated

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

Showing all 4 trials

Adrenal Neoplasm